FDG Hepatic Superscan Due to Metastatic Infiltration of Prostate Cancer
- PMID: 32366788
- DOI: 10.1097/RLU.0000000000003044
FDG Hepatic Superscan Due to Metastatic Infiltration of Prostate Cancer
Abstract
A 69-year-old man with prostate cancer presented to the hospital with 2 weeks' history of fever, abdominal distension, and fatigue. Laboratory findings showed signs of acute liver failure, and marked elevation of lactate dehydrogenase and tumor marker levels. Abdominal CT showed hepatomegaly with multiple hypodense lesions in both lobes, suggesting metastases. FDG PET/CT scan shows hypermetabolism unusually in the liver with significantly suppressed heart and brain activity, reminiscent of an FDG hepatic superscan. The hypermetabolic lesions confirmed with Tru-Cut needle biopsy of the liver as metastasis of prostate cancer.
References
-
- Basu S, Nair N. Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin’s disease: hepatic “superscan.” Clin Nucl Med. 2004;29:626–628.
-
- Tichelaar V, Gemmel F, de Rhoter W, et al. FDG hepatic superscan caused by massive breast cancer invasion. Clin Nucl Med. 2009;34:716–718.
-
- Du B, Li X, Li N, et al. 18F-FDG hepatic superscan in a patient with chronic myeloid leukemia. Clin Nucl Med. 2014;39:835–836.
-
- Mahajan S, Kalra S, Chawla M, et al. Detection of diffuse infiltrative primary hepatic lymphoma on FDG PET-CT: hallmarks of hepatic superscan. World J Nucl Med. 2016;15:142–144.
-
- Muteganya R, Karfis I, Artigas C, et al. Unusual diffuse liver 18F-FDG uptake in melanoma patient treated by ipilimumab. Hell J Nucl Med. 2017;20:179–181.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
